Nathan has over 20 years of wide ranging experience in the Healthcare and Pharmaceutical field as a pharmacist in the government hospital, pharmaceutical manufacturing, community pharmacy and pharmaceutical industry. He won a regional merit award for best regional marketing program in 2004 and global merit award for astounding strategic leadership for the launch of a new novel antipsychotic in 2006. He has successfully participated and completed up to 24 various courses on leadership, process excellence and marketing excellence in addition to numerous local and international scientific conferences participation. He has a certificate in good clinical practice (GCP) and has been involved extensively in coordinating various clinical trials in psychopharmacology (novel antipsychotics and long acting injectable antipsychotics), onychomycosis, multiple myeloma, myelodysplastic syndrome, pneumonia, carbapenem surveillance and renal registry (chronic kidney disease and end stage renal disease).
Nathan Kothandaraman currently has responsibilities for market access and government affairs in policy engagement and facilitating access for various therapeutic categories. He also has obtained course certificates in Health Economics and Health Technology Assessment.